Multi-source·Jul 24, 2026·2 sources analyzed
Federal judge orders FDA to reconsider mifepristone prescribing limits
A federal judge in Virginia ruled that FDA certification and paperwork limits on mifepristone prescribing were inadequately justified, keeping medication-abortion access and any FDA or appellate response in dispute. (sources: reuters)
Image: Modern Action subject: Rules for medication abortion care
Modern Action Briefing
The ruling challenges the legality of restrictions on prescribing an abortion drug. It may lead to changes in how the medication is accessed.
- A US judge issued a ruling against restrictions on prescribing an abortion drug.
- The restrictions were implemented during a previous administration.
- The decision may affect the availability of the medication.
Why it matters
The ruling could influence access to abortion medication and related healthcare policies.
Connected public decisions
Follow the issue pages where this story connects to public action.
Contact officials
Act on Rules for medication abortion care
See the current decision, choose your position, and send a message through the issue page.
Take action on Rules for medication abortion care